According to GlobalData’s medical device pipeline database, 18 Bone Morphogenetic Proteins (BMP) devices are in various stages of development globally. GlobalData’s report Bone Morphogenetic Proteins (BMP) provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, five are in active development, while the remaining 13 are in an inactive stage of development. There are two products in the early stages of development, and the remaining three are in the late stages of development.
Bone Morphogenetic Proteins (BMPs) are low molecular weight, non-collagenous glycoproteins. BMPs include group of growth factors and cytokines known for their ability to induce the formation of bone and cartilage. Human recombinant BMPs (rhBMPs) are mostly used for spine fusion surgeries. In US, one unit is 5ml of rhBMP-2 product or a 20ml vial of OP-1 product. In European countries, one unit is 12mg/8.0ml of rhBMP-2 product (since rhBMP-2 is only available in one size in EU) or a 20ml vial of OP-1 product.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Bone Morphogenetic Proteins (BMP) pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Bone Morphogenetic Proteins (BMP) devices. Overall, most of these Bone Morphogenetic Proteins (BMP) pipeline devices are being developed by private entities.
Key players involved in the active development of Bone Morphogenetic Proteins (BMP) include Adocia, Bio-Scaffold International, Ferring Pharmaceuticals, Medtronic, BoneSupport, Drexel University, Drexel University, Ember Therapeutics, Induce Biologics and Locate Bio.
For a complete picture of the developmental pipeline for Bone Morphogenetic Proteins (BMP) devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.